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Abstract
Background and Objectives: Children born extremely preterm (EPT) are at risk for cognitive 
difficulties and disability. The relative prognostic value of neonatal brain MRI and cranial US 
(CUS) for school-age outcomes remains unclear. Our objectives were to relate near-term 
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conventional brain MRI and early and late CUS to cognitive impairment and disability at 6–7 
years among children born EPT, and assess their prognostic value.
Methods: A prospective study of adverse early and late CUS and near-term conventional MRI 
findings to predict outcomes at 6–7 years including FSIQ <70 and moderate-severe disability 
(FSIQ<70, moderate-severe cerebral palsy, or severely vision or hearing impaired) in a subgroup 
of SUPPORT enrollees. Stepwise logistic regression evaluated associations of neuroimaging with 
outcomes, adjusting for perinatal-neonatal factors.
Results: 386 children had follow up at 6–7 years. In unadjusted analyses, severity of white 
matter abnormality and cerebellar lesions on MRI, and adverse CUS findings were associated with 
6–7 year outcomes. In full regression models, both adverse late CUS findings (OR 27.9, 95%CI 
6.0–129) and significant cerebellar lesions on MRI (OR 2.71, 95% CI 1.1–6.7) remained 
associated with moderate-severe disability, but only adverse late CUS findings (OR 20.1, 95%CI 
3.6–110.8) with FSIQ<70. Predictive accuracy of stepwise models was not substantially improved 
with addition of neuroimaging.
Conclusions: Severe but rare adverse late CUS findings were most strongly associated with 
cognitive impairment and disability at school-age, and significant cerebellar lesions on MRI were 
associated with disability. Near-term conventional MRI did not substantively enhance prediction of 
FSIQ<70 or moderate-severe disability at early school age.
INTRODUCTION
Children born extremely preterm (EPT, born less than 28 weeks’ gestation) are at increased 
risk for global cognitive delays, motor challenges including cerebral palsy (CP), and 
functional disabilities in childhood. At 8 years, one-half of children born EPT in the Victoria 
Infant Collaborative had some cognitive delay and 15% had major cognitive delay compared 
to term-born children (1). Moderate or severe motor impairment was reported in more than 
one-quarter of children born at <30 weeks’ gestation at 5 years (2). In a population-based 
Swedish study of infants born <27 weeks’ gestation at 6 years, nearly 30% had moderate or 
severe cognitive delay compared with 2.5% of term children (3). A 10-fold greater risk for 
intellectual or learning disability was seen at 11-years of age among children born <26 
weeks’ gestation compared with term in the EPICure cohort (4). With increasing survival of 
infants born EPT (5), an enhanced understanding of neonatal predictors of childhood 
outcomes is important to accurate counseling and to inform future interventions to 
ameliorate later impairments.
Numerous studies have demonstrated adverse neonatal neuroimaging findings among infants 
born EPT are associated with neurologic and developmental challenges in later childhood. 
Cranial ultrasound (CUS) is the routine neuroimaging modality for this patient population, 
and allows for serial bedside imaging. However, conventional brain magnetic resonance 
imaging (MRI) performed at near-term equivalent age is more sensitive to white matter 
abnormalities (WMA) (6,7), and other findings including cerebellar injury (8). Links 
between WMA on neonatal brain MRI and later childhood cognitive, motor, and psychiatric 
challenges have also been shown (2, 9, 10). Adverse neonatal CUS findings among children 
born EPT have been similarly shown to be strongly associated with outcomes at 2 and 8 
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years, particularly when markers of WM injury are considered (11,12). Some authors have 
emphasized the imprecision of qualitative neonatal neuroimaging in outcomes prediction 
(13), while others advocate the value of CUS as a screening and serial imaging tool, but 
suggest term equivalent brain MRI may more accurately predict cognitive outcomes (14).
The Eunice Kennedy Shriver National Institute of Child Health and Human Development 
(NICHD) Neonatal Research Network (NRN) developed the Neuroimaging and 
Neurodevelopmental Outcomes (NEURO) study, a prospective study of early and near-term 
CUS, near-term brain MRI among infants born EPT, and neurodevelopmental outcomes at 
18–22 months corrected age (15) and school-age. Our objectives were to relate early and late 
neonatal CUS adverse findings, and WM abnormalities and cerebellar lesions by near term 
brain MRI, to outcomes at 6–7 years including cognitive impairment and moderate-severe 
disability; and to assess the relative value of neonatal neuroimaging, in combination with 
other perinatal and neonatal risk factors, to predict these adverse outcomes.
METHODS
Study design and population
The NEURO study was a secondary study to The Surfactant Positive Airway Pressure and 
Pulse Oximetry Randomized Trial (SUPPORT), a randomized, multicenter trial of 
ventilation and oxygenation management strategies among infants at 24–27+6/7 weeks’ 
gestation (16, 17). The NEURO study cohort represents a subgroup of the SUPPORT cohort, 
as it was approved and began recruitment after SUPPORT began enrollment, and not all 
centers participated nor did they launch simultaneously (15). The study was approved by the 
institutional review boards (IRB) of all participating centers, and by the IRB of Research 
Triangle Institute (RTI) International, the Data Coordinating Center for the NICHD NRN.
Neonatal neuroimaging: Cranial US and brain MRI
Cranial US: An “early” CUS at 4–14 days of age, and a “late” CUS at 35–42 weeks’ 
postmenstrual age (PMA) were obtained for NEURO study participants. Cranial US imaging 
was obtained per local center clinical protocol, and did not specify views. Central reader 
interpretations were used for all study analyses. Two masked central readers (DB, TS) 
reviewed all study CUS independently utilizing a modified central reading form used in 
previous NICHD NRN studies (18). A composite adverse finding on early CUS was defined 
as presence of grade III or IV intracranial hemorrhage (ICH) (19) or cystic periventricular 
leukomalacia (cPVL) on either or both sides. A composite adverse finding on late CUS was 
defined as cPVL, or porencephalic cyst, or moderate-severe ventricular enlargement (VE) on 
either or both sides, or a shunt. For all CUS, assessment of interobserver reliability between 
central readers demonstrated kappa=0.75 for the early CUS composite adverse finding, and a 
kappa = 0.88 for the late CUS composite adverse finding. Mastoid views were included in 
only 48.2% of early CUS and 46.1% of late CUS (15).
Brain MRI: A conventional brain MRI was obtained at 35–42 weeks PMA, and within 2 
weeks of late CUS. Minimum requirements have been previously described (15), and it was 
advised that neonatal brain MRIs be obtained without the use of sedation. Central reader 
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interpretations were used for study analyses. Copies of MRIs were sent to RTI International 
by sites in digital or film format. A masked central reader (PDB) reviewed all brain MRIs 
utilizing a central reader form that included WMA scoring according to a widely used 
classification system that evaluated 5 areas of WM assessment (6, 20). Interrater agreement 
for moderate or severe WMA by using this classification system has been reported to be 
>95% (20). Significant cerebellar lesions were defined as lesions that were bilateral, cystic, 
and/or ≥4 mm in size. Adverse findings on brain MRI were defined as moderate or severe 
WMA, or significant cerebellar lesions.
Neurodevelopmental follow up assessments at early school age
The school age visit occurred at 6 years 4 months to 7 years 2 months of age, and included a 
battery of assessments and questionnaires. For this analysis, general intellectual, motor, and 
neurosensory function were the focus. General intellectual functioning was assessed using 
the full scale intelligence quotient (FSIQ) of the Wechsler Intelligence Scale for Children-
Fourth Edition (WISC-IV) (21) (age standardized scores for FSIQ are mean = 100 and 
standard deviation (SD) = 15). Neurologic examination included assessment for CP (22), 
with severity assigned according to the Gross Motor Function Classification System level 
(GMFCS) (23, 24). Determination of vision and hearing was both by assessment and parent 
report at visit. Severe vision impairment was defined as blind or able to perceive only light 
in both eyes, or only perceive light in one eye, with the other eye with impairment that is not 
correctable with glasses, or lenses. Severe hearing impairment was defined as no useful 
hearing even with hearing aid(s), implant(s), or other amplification device, or if hearing 
impairment is profound and considered not responsive to amplification. Examiners and 
coordinators from all study sites were required to attend a two-day training session. For both 
the WISC-IV and neurologic exam, site examiners were then required to be certified prior to 
their first study visit including submission of a DVD of study assessments with an age 
appropriate child. Site examiners were re-certified at the mid-point of the study follow up 
period.
The prospectively defined outcomes were 1) significant cognitive impairment defined as 
FSIQ<70, and 2) moderate to severe disability defined as FSIQ <70 or CP with GMFCS >=2 
or severe hearing impairment or severe vision impairment. Other outcomes were evaluated 
including FSIQ <85; minimal or no disability which was defined as having all of the 
following: FSIQ>85, no CP, no hearing or vision impairment or impairments that were 
completely correctable; and severe disability, which was defined as FSIQ <55 or CP with 
GMFCS 4 or 5, or severe hearing or severe vision impairment.
Statistical Analyses
The unadjusted associations between neonatal neuroimaging findings and school age 
outcomes were examined by chi-square test, Fisher’s exact test, or analysis of variance 
(ANOVA). We determined test characteristics of neonatal adverse findings for school age 
outcomes by sensitivity, specificity, positive predictive value (PPV) and negative predictive 
value (NPV). To evaluate the relative predictive value of early CUS, late CUS, and MRI 
findings, we developed a series of generalized linear mixed models to predict the binary 
outcomes of FSIQ<70 and moderate to severe disability by neuroimaging findings, 
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controlling for NRN center and perinatal/neonatal risk factors. Risk factors were selected for 
inclusion as control variables in each model based on backwards stepwise regression with 
retention criterion of p < .10. Potential risk factors included: EGA (24–25+6/7 weeks vs. 26–
27+6/7 weeks), race, male, multiple gestation, maternal education less than high school, 
late-onset sepsis, BPD, postnatal steroids (PNS), and surgery for PDA or NEC or ROP. 
Neuroimaging findings included 1) Early CUS composite adverse finding; 2) Late CUS 
composite adverse finding; 3) Moderate or severe WMA based on MRI; and 4) significant 
cerebellar lesions based on MRI. Results of the models were expressed as odds ratios (OR) 
and 95% confidence intervals (CI). We then conducted receiver-operating characteristic 
(ROC) curve analyses from these models, and compared the predictive capabilities on the 
basis of the area under the curve (AUC) of the ROC curves.
RESULTS
480 infants had complete neuroimaging with late CUS and brain MRI within 2 weeks of 
each other, of whom 17 were known to have died after all neuroimaging was obtained and 
before 6–7 years. 77 children were lost to follow up for the school age visit (36 lost without 
further information, families of 35 declined, 3 were adopted, and 3 were out of state or 
country, and travel could not be arranged within the visit window). Therefore, 386 children 
had school age visit data (83.3% follow up among survivors), for whom determination of 
FSIQ<70 could be made in 373, and moderate to severe disability in 379 (96% and 98%, 
respectively, of those with study visit data). The presence or absence of CP was determined 
in all 386 children. The mean +/− SD age at visit was 6.35 +/− 0.54 years.
Perinatal, neonatal, and demographic variables for participants in school age follow up and 
for those lost to follow up are shown in Table 1 [SUPPLEMENTAL]. The participants and 
lost to follow up groups were similar overall with the exception of a slightly higher mean 
EGA at delivery and lower rates of postnatal steroid use among those who returned for the 
study visit. For participants in the school age visit, approximately 62% had no or minimal 
disability, and 55% had WISC-IV FSIQ ≥85. Only 5 children had severe visual impairment 
(1.3%), and 1 had severe hearing impairment.
Brain MRI findings in relation to cognitive impairment and disability are shown in Table 2. 
Increasing severity of WMA (Table 2A) and presence of cerebellar lesions (Table 2B) were 
associated with significantly lower mean FSIQ, higher rates of FSIQ < 70 and < 85, higher 
rates of moderate to severe disability, and lower rates of minimal or no disability. Among 
those with moderate and severe WMA combined, the rate of FSIQ < 70 was 23%, and 
moderate-severe disability was 31%. Early and late neonatal CUS findings in relation to 
outcomes are shown in Table 3. Both adverse early and late CUS findings were associated 
with lower mean FSIQ, higher rates of FSIQ <70 and <85, and with moderate to severe 
disability, but the strength of the association was more substantial for late CUS (Table 3B). 
Of note, the numbers of children with adverse early CUS findings (n=33) or adverse late 
CUS findings (n=22) were low. Diagnostic validity of adverse neuroimaging findings for 
selected school age outcomes reveal overall poor sensitivity of adverse neonatal 
neuroimaging for school age outcomes, with good to excellent specificity (Table 4). The 
PPVs of adverse early CUS or adverse MRI findings were poor for FSIQ<70 and moderate-
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severe or severe disability, and of adverse late CUS were only fair-moderate for FSIQ<85 
and moderate-severe disability. However, the NPVs for the most severe school age outcomes 
were 88%−96% for all neuroimaging.
Results of stepwise multivariable models are shown in Figure 1. Early CUS adverse findings 
were not significantly associated with either outcome when any other imaging was taken 
into account. In full regression models, for the outcome of FSIQ<70, only late CUS findings 
remained independently associated among neonatal neuroimaging variables. For moderate-
severe disability, both late CUS findings and significant cerebellar lesions on MRI remained 
independently associated with the outcome. The magnitude of the association with late CUS 
findings was substantial for both outcomes, although the 95% CI were wide. In limited 
models excluding late CUS, MRI findings were not significantly associated with either 
outcome; however, for moderate-severe disability, the association with both moderate-severe 
WMA (p=0.056) and significant cerebellar lesions (p=0.058) approached significance. In 
limited models excluding MRI, late CUS adverse findings, but not early CUS adverse 
findings, remained significantly associated with both outcomes. Results of the ROC curve 
analyses are shown in Table 5. Point estimates of model AUCs improved slightly with 
addition of neuroimaging compared with models that included only perinatal-neonatal 
variables for both outcomes. Importantly however, 95% CI of the AUCs for all models 
overlapped substantially.
DISCUSSION
We found that adverse findings on neonatal early and late CUS and MRI were associated 
with 6–7 year outcomes in unadjusted analyses. Sensitivity and PPV of adverse 
neuroimaging findings were poor for FSIQ<70 and moderate-severe disability, although 
NPV was very good to excellent. In multivariable models, severe but rare late CUS findings 
remained strongly independently associated with both FSIQ<70 and moderate-severe 
disability, but with wide confidence intervals. Significant cerebellar lesions on brain MRI 
also remained associated with moderate-severe disability, but prognostic capabilities as 
assessed by AUC point estimates improved only marginally with addition of neuroimaging, 
with 95% CI overlapping broadly. Our findings demonstrate that prediction of FSIQ<70 and 
moderate-severe disability is not substantively improved over and above CUS by the 
addition of conventional MRI at near-term. They further highlight uncertainty in positive 
prediction of complex school-age outcomes from perinatal and neonatal factors, including 
adverse neonatal neuroimaging findings.
Other investigators have shown independent associations of moderate-severe WMA on 
neonatal MRI with early childhood and school age cognitive outcomes, which would seem 
to be in contrast with our findings. But those studies have varied in design, with some 
considering only high grade ICH or cPVL rather than later CUS findings (20), or showing 
that qualitative conventional term MRI reveals little additional data than CUS done on the 
same day to predict adverse outcomes at 2 or 6 years (25, 26). Some previous school age 
studies also focus narrowly on predictive capabilities of MRI findings without a goal of 
comparison to CUS (9, 27). Others have reported on prognostic validity of severe CUS 
findings alone for long term outcomes. Similar to our findings, the EPIPAGE group reported 
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that significant cognitive impairment and moderate-severe disability at 8 years were most 
strongly associated with severe neonatal neuroimaging findings, particularly adverse near 
term CUS findings (13). Nonetheless, the severe findings did not systematically predict poor 
cognitive outcomes and disability in that cohort. This is consistent with our results, which 
demonstrated only moderate PPV of late CUS for moderate-severe disability, although better 
than early CUS or MRI.
Our prospective objective for this analysis of the NEURO study school age follow up was to 
determine the relative value of adverse findings on early and late CUS and near-term brain 
MRI to predict significant impairments at school age. We acknowledge that the outcomes 
examined in this study were on the severe end of the spectrum, and prospective prediction 
from adverse, but in this patient group rare, neuroimaging findings. However, although 
positive prediction of our main outcomes was generally poor or at best moderate, it is 
important to note that NPV for adverse findings at early school age was very good to 
excellent. We will be able to augment our findings in the future analyses given the 
comprehensive nature of the NEURO school age visit data. Neonatal MRI WMA has been 
shown to be associated with non-CP motor outcomes such as developmental coordination 
disorder, which is prevalent among children born preterm, and can significantly affect their 
school age functional capabilities and even academic performance (28). Cerebellar injury 
among extremely preterm infants has been associated with both motor and cognitive 
impairment (29), and with impaired growth of cortical regions that has been linked with 
cognitive, motor, and neuropsychiatric challenges (30). Although cerebellar lesions may be 
visualized by appropriate CUS views, smaller lesions are much more likely to be seen by 
MRI (31). Nevertheless, the impact of these smaller lesions on developmental outcomes 
remains unclear. Some have reported no association of small cerebellar hemorrhages (<4 
mm) with 2 year neurodevelopmental outcomes (32), while others have reported associations 
with later abnormalities on neurologic exam, but not with functional ambulation 
impairments or significant differences in developmental testing at 3–6 years (8). In our study 
we found an independent association of significant cerebellar lesions with disability but not 
cognitive delay, and no substantive enhancement of predictive capabilities. It is also possible 
that significant cerebellar lesions could have been better detected by CUS had mastoid and 
posterior fossa views been required as part of the study protocol (33), and that overall 
quality of CUS images could have been enhanced with more stringent CUS protocol. Our 
findings highlight the importance of including CUS sequences to optimize cerebellar views.
We also recognize that since the NEURO study was initially launched, an expanded and 
globally more detailed scoring system for abnormalities on qualitative brain MRI was 
published (34), which has subsequently been shown to be associated with lower IQ, math 
and motor scores (35), and poorer memory and learning performance (36) at 7 years among 
very preterm children. However, in a recent extremely preterm Dutch cohort, the prognostic 
value of that MRI scoring system for 2-year outcomes was limited (37). Our study also 
focused on the MRI WMA component of the older classification system, and not grey 
matter. Our large, multicenter study called for conventional, qualitative brain MRI at near 
term with a goal of generalizability, based on the recognition that not all institutions have 
advanced imaging approaches available. Furthermore, our study is differentiated from most 
others in that it called for both early and late CUS, the modality that continues to be the 
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mainstay of neuroimaging for extremely preterm infants in the NICU, with the objective of 
assessing the relative predictive value of conventional neuroimaging tools in this cohort. 
Nonetheless, advanced and quantitative neuroimaging may hold promise in predicting 
childhood outcomes for preterm infants at 2–3 years (38) and in later childhood (39, 40). 
Continued research of advanced imaging techniques may better connect patterns of neonatal 
injury with disrupted brain development, and identify opportunities to prevent such injury.
CONCLUSION:
Our findings underscore the sustained influence of severe neonatal brain injury, but also add 
to our understanding of prognostic uncertainty for individual preterm infants even with serial 
brain imaging. Neonatologists making decisions regarding need for near-term conventional 
brain MRI should be cognizant of the complexities of outcomes and limitations to predict 
them, the incremental benefits relative to increased costs (41), and the varying perspectives 
of the meaning of outcomes to patients and families, physicians, and investigators (42–44). 
Although near-term MRI did not substantively improve prediction of school age outcomes 
over and above CUS in this study, the outcomes examined were severe, and prospective 
prediction was from rare and significantly adverse imaging findings. Further analyses from 
this dataset may delineate when and whether the information gained by near-term 
conventional MRI can provide improved prognostic or supportive capabilities.
ACKNOWLEDGEMENTS:
Maureen Hack, MD, Professor of Pediatrics and Obstetrics & Gynecology, Case Western Reserve University, died 
on June 4, 2015. Dr. Hack was a member of the SUPPORT Neuroimaging and Neurodevelopmental Outcomes 
Secondary Protocol Subcommittee, and made critical contributions to the development of the study and to this 
research.
Thomas L. Slovis, MD, Professor of Radiology and Pediatrics, Wayne State University School of Medicine and 
Children’s Hospital of Michigan, died on February 6, 2018. Dr. Slovis was one of the central readers for neonatal 
cranial ultrasounds, he was a crucial contributor to the SUPPORT Neuroimaging and Neurodevelopmental 
Outcomes study, and he read and made critical revisions to the original version of this manuscript before initial 
submission.
The National Institutes of Health, the Eunice Kennedy Shriver National Institute of Child Health and Human 
Development (NICHD), and the National Heart, Lung, and Blood Institute (NHLBI) provided grant support for the 
Neonatal Research Network’s Extended Follow-up at School Age for the SUPPORT Neuroimaging and 
Neurodevelopmental Outcomes (NEURO) Cohort through cooperative agreements. While NICHD staff had input 
into the study design, conduct, analysis, and manuscript drafting, the comments and views of the authors do not 
necessarily represent the views of the NICHD.
Data collected at participating sites of the NICHD Neonatal Research Network (NRN) were transmitted to RTI 
International, the data coordinating center (DCC) for the network, which stored, managed and analyzed the data for 
this study. On behalf of the NRN, Drs. Abhik Das (DCC Principal Investigator), Marie Gantz, Lisa Wrage, and 
Helen Cheng (DCC Statisticians) had full access to all the data in the study and take responsibility for the integrity 
of the data and accuracy of the data analysis.
We are indebted to our medical and nursing colleagues, and the infants and their parents who agreed to take part in 
this study.
Funding source: The National Institutes of Health, the Eunice Kennedy Shriver National Institute of Child Health 
and Human Development (NICHD), and the National Heart, Lung, and Blood Institute (NHLBI) provided grant 
support for the Neonatal Research Network’s SUPPORT Trial Neuroimaging Secondary Protocol through 
cooperative agreements. While NICHD staff had input into the study design, conduct, analysis, and manuscript 
drafting, the comments and views of the authors do not necessarily represent the views of the NICHD. A complete 
Hintz et al. Page 9
Pediatrics. Author manuscript; available in PMC 2018 September 08.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
list of investigators by participating center can be found in Appendix 1. Dr. Hintz received support for her efforts in 
this study as an Arline and Pete Harman Endowed Faculty Scholar, Lucile Packard Children’s Hospital Stanford.
Abbreviations:
CUS cranial ultrasound
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WISC-IV Wechsler Intelligence Scale for Children-Fourth Edition
SUPPORT Surfactant Positive Airway Pressure and Pulse Oximetry 
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What is Known on This Subject:
Adverse neonatal neuroimaging findings among extremely preterm infants are associated 
with neurologic and developmental challenges in later childhood. But the relative 
prognostic value of near-term brain MRI and cranial US for severe school-age outcomes 
remains unclear.
What this Study Adds:
Severe but rare adverse late CUS findings were most strongly associated with FSIQ<70 
and moderate-severe disability at school-age. Near-term conventional MRI did not 
substantively enhance prediction. Prognostic uncertainty remains even in the setting of 
serial brain imaging.
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Figure 1. Independent associations of neonatal neuroimaging findings with cognitive impairment 
and moderate-severe disability at early school age
* p < 0.05, *** p < 0.001.
Note: Early CUS composite adverse finding defined as Grade III or IV ICH or cPVL. Late 
CUS composite adverse finding defined as moderate or severe ventricular enlargement, or 
cPVL, or porencephalic cyst, or shunt. Full model included the following perinatal, neonatal, 
and sociodemographic factors that were associated with p < 0.2 in backwards stepwise 
models: FSIQ < 70: Male (OR 2.07, 95% CI 1.0–4.28; p=0.049), maternal education <HS 
(OR 2.05, 95% CI 0.98–4.29; p=0.056), BPD (OR 1.59, 95% CI 0.78–3.23; p=0.20); 
Moderate-severe disability: Male (OR 1.93, 95% CI 0.98–3.80; p=0.057), BPD (OR 1.30, 
95% CI 0.67–2.50; p=0.44). Limited Model 1 includes perinatal/neonatal factors + Early 
CUS+ Brain MRI (excludes Late CUS); Limited Model 2 includes perinatal/neonatal factors 
+ Early CUS + Late CUS (excludes MRI).
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Table 1.
Baseline perinatal, demographic and neonatal characteristics, and selected 6–7 year outcomes for participants 
at school age follow up and those lost to follow up.
Characteristic Participants
N=386
Lost to follow up
N=77
p-value
n (%) n (%)
BW (mean +/− SD) 861.8 ± 190.1 823.6 ± 182.8 .105
EGA (mean +/− SD) 25.9 ± 1.0 25.7 ± 1.0 .044
24 −25 weeks 137 (35) 34 (44) .150
Multiple gestation 89 (23) 16 (21) .663
Race .385
 Non-Hispanic black 128 (33) 18 (23)
 Non-Hispanic white 162 (42) 38 (49)
 Hispanic 85 (22) 18 (23)
 Other 11 (3) 3 (4)
Male 209 (54) 45 (58) .489
Any antenatal steroids 371 (96) 75 (97) .583
Cesarean section 260 3 (67) 57 (74) .250
Maternal education < High school 96/379 (25) 22/74 (30) .430
*
 Late sepsis 119 (31) 28 (36) .341
NEC (stage 2 or greater) 29 (8) 4 (5) .470
†Severe ROP 40/359 (11) 11/70 (16) .280
Surgery for PDA or NEC or ROP 72 (19) 16 (21) .664
‡Postnatal steroids 27/383 (7) 11/76 (14) .032
§BPD 142 (37) 34 (44) .224
Neonatal neuroimaging
Early CUS adverse finding 35 (9) 9 (12) .478
Late CUS adverse finding 24 (6) 2 (3) .208
Moderate or severe WMA on MRI 72 (19) 16 (21) .664
Any cerebellar lesions on MRI 60 (16) 15 (19) .392
Significant cerebellar lesions on MRI 42 (11) 7 (9) .641
6–7 year major outcomes
FSIQ (mean +/− SD), n=373) 85.6 +/− 17.4
FSIQ<70 47/373 (13)
FSIQ<85 169/373 (45)
Moderate-severe disability 57/379 (15)
Minimal or no disability 234/379 (62)
*
Late sepsis: culture-proven sepsis from 7 days of age to discharge and treated with antibiotics for at least 5 days.
†Severe retinopathy of prematurity (ROP): threshold ROP, ophthalmologic surgery, or the use of bevacizumab treatment for retinopathy
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‡
Postnatal steroids: any corticosteroid given for prevention or treatment of bronchopulmonary dysplasia
§
BPD: Oxygen use at 36 weeks PMA
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